Pradžia › Psoriazinis artritas
Psoriazinis artritas klinikiniai tyrimai JAV ieško dalyvių
30 tyrimai dėl Psoriazinis artritas ieško dalyvių vietose visoje Jungtinėse Valstijose.
Miestai su daugiausia tyrimų
- Houston, TX8 tyrimai
- Charlotte, NC7 tyrimai
- Parma, OH6 tyrimai
- Tampa, FL6 tyrimai
- Philadelphia, PA6 tyrimai
- Altoona, PA6 tyrimai
- Cleveland, OH5 tyrimai
- Plantation, FL5 tyrimai
- Clearwater, FL5 tyrimai
- New York City, NY5 tyrimai
- Milwaukee, WI5 tyrimai
- San Diego, CA5 tyrimai
- Hialeah, FL4 tyrimai
- Phoenix, AZ4 tyrimai
- Huntington Beach, CA4 tyrimai
- Baytown, TX4 tyrimai
- Thousand Oaks, CA4 tyrimai
- Albuquerque, NM4 tyrimai
- Jackson, TN4 tyrimai
- Dallas, TX4 tyrimai
- Seattle, WA4 tyrimai
- The Woodlands, TX4 tyrimai
- Baltimore, MD4 tyrimai
- Kansas City, MO4 tyrimai
- Tucson, AZ4 tyrimai
- Durham, NC4 tyrimai
- Orlando, FL4 tyrimai
- Arlington, TX4 tyrimai
- Brooklyn, NY3 tyrimai
- Lubbock, TX3 tyrimai
- Mesquite, TX3 tyrimai
- Hagerstown, MD3 tyrimai
- Hollywood, FL3 tyrimai
- Lansing, MI3 tyrimai
- St. Louis, MO3 tyrimai
- Mesa, AZ3 tyrimai
- Fort Worth, TX3 tyrimai
- Austin, TX3 tyrimai
- Columbus, OH3 tyrimai
- Washington, DC3 tyrimai
Pagal valstiją
- Arizona8 tyrimai
- Arkansas4 tyrimai
- Džordžija7 tyrimai
- Florida14 tyrimai
- Ilinoisas6 tyrimai
- Indianas4 tyrimai
- Kalifornija13 tyrimai
- Kentukis3 tyrimai
- Koloradas4 tyrimai
- Kolumbijos apskritis3 tyrimai
- Konektikutas3 tyrimai
- Masčusetsas4 tyrimai
- Merilendas7 tyrimai
- Misūris5 tyrimai
- Mičiganas4 tyrimai
- New Jersey3 tyrimai
- New Mexico4 tyrimai
- New York8 tyrimai
- North Carolina11 tyrimai
- Ohio14 tyrimai
- Oregon3 tyrimai
- Pennsylvania12 tyrimai
- South Carolina3 tyrimai
- Tennessee7 tyrimai
- Texas17 tyrimai
- Utah3 tyrimai
- Washington6 tyrimai
- Wisconsin5 tyrimai
Nesenai atnaujinti tyrimai
Oficialus tyrimo tekstas (anglų kalba)
A Study to Evaluate the Efficacy and Safety of Icotrokinra (JNJ-77242113) in Biologic-experienced and Biologic-naive Participants With Active Psoriatic Arthritis
Renkami dalyviai3 fazė
Amžius 18 ir vyresni · Visoms lytims · Atnaujinta 2026-09-25 · NCT06807424A Long-term Extension (LTE) Study of Guselkumab in Pediatric Participants
Renkami dalyviai3 fazė
Amžius 3 ir vyresni · Visoms lytims · Atnaujinta 2026-09-25 · NCT06663332A Study to Evaluate the Efficacy and Safety of JNJ-88545223 for the Treatment of Participants With Active Psoriatic Arthritis
Renkami dalyviai2 fazė
Amžius 18 ir vyresni · Visoms lytims · Atnaujinta 2026-09-25 · NCT07321873A Study to Assess the Efficacy, Safety and Tolerability of DDY391 in Participants With Moderate to Severe Psoriatic Arthritis
Renkami dalyviai2 fazė
Amžius nuo 18 iki 100 · Visoms lytims · Atnaujinta 2026-09-25 · NCT07801495Testing an Immunotherapy Anti-cancer Drug, Nivolumab, for Advanced Cancers in Patients With Autoimmune Disorders, AIM-NIVO
Renkami dalyviai1 fazė
Amžius 18 ir vyresni · Visoms lytims · Atnaujinta 2026-09-23 · NCT03816345A Study to Assess the Concentration of Bimekizumab in Mature Breast Milk From Mothers Receiving Treatment With Bimzelx® (Bimekizumab)
Renkami dalyviai1 fazė
Amžius 18 ir vyresni · Moterims · Atnaujinta 2026-09-18 · NCT06888193A Study of Zasocitinib in Adults With Psoriatic Arthritis Who Have Not Taken Biologic Medicines
Renkami dalyviai3 fazė
Amžius 18 ir vyresni · Visoms lytims · Atnaujinta 2026-09-17 · NCT06671483Study to Evaluate Tulisokibart in Adults With Psoriatic Arthritis (MK-7240-015)
Renkami dalyviai2 fazė
Amžius nuo 18 iki 80 · Visoms lytims · Atnaujinta 2026-09-14 · NCT07486960Evaluation of Sonelokimab in Patients With Active Psoriatic Arthritis and Anti-TNFα Inadequate Response
Renkami dalyviai3 fazė
Amžius 18 ir vyresni · Visoms lytims · Atnaujinta 2026-09-11 · NCT06641089A Study of Zasocitinib in Adults With Psoriatic Arthritis Who Have or Have Not Been Treated With Biologic Medicines
Renkami dalyviai3 fazė
Amžius 18 ir vyresni · Visoms lytims · Atnaujinta 2026-09-09 · NCT06671496Continuation Study of Zasocitinib in Adults With Psoriatic Arthritis
Renkami dalyviai3 fazė
Amžius 18 ir vyresni · Visoms lytims · Atnaujinta 2026-09-09 · NCT07286058Deucravacitinib-TNFi Combination Therapy for Difficult-to-Control Psoriatic Disease
Renkami dalyviai4 fazė
Amžius nuo 18 iki 65 · Visoms lytims · Atnaujinta 2026-09-01 · NCT07280702A Study to Assess Adverse Events, Change in Disease Activity, and How the Drug Moves Through the Body in Children With Juvenile Psoriatic Arthritis (jPsA) Receiving Subcutaneously Injected Risankizumab or Adalimumab
Renkami dalyviai3 fazė
Amžius nuo 5 iki 17 · Visoms lytims · Atnaujinta 2026-09-01 · NCT06100744A Study to Assess Concentration of TREMFYA in Breast Milk of Lactating Women Who Are Receiving TREMFYA Therapeutically
Renkami dalyviai4 fazė
Amžius 18 ir vyresni · Moterims · Atnaujinta 2026-08-28 · NCT07654751Observational Study of Pediatric Rheumatic Diseases: The CARRA Registry
Renkami dalyviaiStebimasis tyrimas
Iki 21 metų · Visoms lytims · Atnaujinta 2026-08-27 · NCT02418442Impact of Glucagon-like Peptide-1 (GLP-1) Analogs on Disease Outcomes in Psoriatic Arthritis: A Pragmatic Randomized Controlled Trial
Renkami dalyviai4 fazė
Amžius 18 ir vyresni · Visoms lytims · Atnaujinta 2026-08-10 · NCT07111494Creating Health Course Study for People With Rheumatological Conditions and Mood Disorders
Renkami dalyviai
Amžius nuo 18 iki 100 · Visoms lytims · Atnaujinta 2026-08-10 · NCT07180537Immunosuppressant Management in Rheumatology Patients Undergoing Elective Total Shoulder Arthroplasty
Renkami dalyviai2 fazė
Amžius 18 ir vyresni · Visoms lytims · Atnaujinta 2026-07-09 · NCT07138898A Study to Learn if Bimekizumab Given in Different Ways is Safe and Moves Similarly Throughout the Body Over Time in Adults
Renkami dalyviai1 fazė
Amžius 18 ir vyresni · Visoms lytims · Atnaujinta 2026-07-06 · NCT07290036Elucidating Shared Mechanisms Contributing to NAFLD and PsA Disease Severity With Guselkumab Therapy
Renkami dalyviai
Visi amžiai · Visoms lytims · Atnaujinta 2026-06-10 · NCT06586281Testing of an Educational Tool for Patients With Melanoma and Pre-Existing Autoimmune Disease Who Are Candidates for Immune Checkpoint Inhibitors
Renkami dalyviaiStebimasis tyrimas
Amžius 18 ir vyresni · Visoms lytims · Atnaujinta 2026-05-20 · NCT04751396A Study to Evaluate the Impact of Upadacitinib on Spondyloarthritis Outcomes in Patients With Active Psoriatic Arthritis
Renkami dalyviai4 fazė
Amžius 18 ir vyresni · Visoms lytims · Atnaujinta 2026-04-03 · NCT06454188Rheumatology Patient Registry and Biorepository
Renkami dalyviaiStebimasis tyrimasLaukiami sveiki savanoriai
Amžius nuo 18 iki 99 · Visoms lytims · Atnaujinta 2026-02-13 · NCT04402086Unhide® Project: A Digital Health Platform to Collect Lifestyle Data for Brain Inflammation Research
Renkami dalyviaiStebimasis tyrimasLaukiami sveiki savanoriai
Amžius 2 ir vyresni · Visoms lytims · Atnaujinta 2026-01-22 · NCT04806620Study of Targeted Therapies for the Treatment of Adult Participants With Active Psoriatic Arthritis
Renkami dalyviai2 fazė
Amžius 18 ir vyresni · Visoms lytims · Atnaujinta 2025-12-18 · NCT06865105Iš ClinicalTrials.gov, duomenys gauti 2026-10-05. Kiekvienas tyrimas nustato savo tinkamumo kriterijus; tyrimo komanda sprendžia, kas gali dalyvauti.